Browse > Article
http://dx.doi.org/10.3831/KPI.2014.17.022

Hepatoprotective Evaluation of Ganoderma lucidum Pharmacopuncture: In vivo Studies of Ethanol-induced Acute Liver Injury  

Jang, Sun-Hee (Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University)
Cho, Sung-Woo (Department of Oriental Rehabilitation Medicine, College of Korean Medicine, Dong-Eui University)
Yoon, Hyun-Min (Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University)
Jang, Kyung-Jeon (Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University)
Song, Chun-Ho (Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University)
Kim, Cheol-Hong (Department of Acupuncture & Moxibution, College of Korean Medicine and Research Institute of Korean Medicine, Dong-Eui University)
Publication Information
Journal of Pharmacopuncture / v.17, no.3, 2014 , pp. 16-24 More about this Journal
Abstract
Objectives: Alcohol abuse is a public issue and one of the major causes of liver disease worldwide. This study was aimed at investigating the protective effect of Ganoderma lucidum pharmacopuncture (GLP) against hepatotoxicity induced by acute ethanol (EtOH) intoxication in rats. Methods: Sprague-Dawley (SD) rats were divided into 4 groups of 8 animals each: normal, control, normal saline pharmacopuncture (NP) and GLP groups. The control, NP and GLP groups received ethanol orally. The NP and the GLP groups were treated daily with injections of normal saline and Ganoderma lucidum extract, respectively. The control group received no treatment. The rats in all groups, except the normal group, were intoxicated for 6 hours by oral administration of EtOH (6 g/kg BW). The same volume of distilled water was administered to the rats in the normal group. Two local acupoints were used: Qimen (LR14) and Taechung (LR3). A histopathological analysis was performed, and the liver function and the activities of antioxidant enzymes were assessed. Results: GLP treatment reduced the histological changes due to acute liver injury induced by EtOH and significantly reduced the increase in the alanine aminotransferase (ALT) enzyme; however, it had an insignificant effect in reducing the increase in aspartate aminotransferase (AST) enzyme. It also significantly ameliorated the superoxide dismutase (SOD) and the catalase (CAT) activities. Conclusion: The present study suggests that GLP treatment is effective in protecting against ethanol-induced acute hepatic injury in SD rats by modulating the activities of ethanol-metabolizing enzymes and by attenuating oxidative stress.
Keywords
acute liver injury; aminotransferase; catalase; Ganoderma lucidum pharmacopuncture (GLP); superoxide dismutase;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kurose I, Higuchi H, Kato S, Miura S, Watanabe N, Kamegaya Y, et al. Oxidative stress on mitochondria and cell membrane of cultured rat hepatocytes and perfused liver exposed to ethanol. Gastroenterology. 1997;112(4):1331-43.   DOI   ScienceOn
2 Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology. 1997;25(2):351-5.   DOI   ScienceOn
3 Wieland P, Lauterburg BH. Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun. 1995;213(3):815-9.   DOI   ScienceOn
4 Masini A, Ceccarelli D, Gallesi D, Giovannini F, Trenti T. Lipid hydroperoxide induced mitochondrial dysfunction following acute ethanol intoxication in rats. the critical role for mitochondrial reduced glutathione. Biochem Pharmacol. 1994;47(2):217-24.   DOI   ScienceOn
5 Bury RW, Desmond PV, Mashford ML, Westwood B, Shaw G, Breen KJ. The effect of ethanol administration on the disposition and elimination of chlormethiazole. Eur J Clin Pharmacol. 1983;24(3):383-5.   DOI
6 Nagy LE. Molecular aspects of alcohol metabolism: transcription factors involved in early ethanol-induced liver injury. Annu Rev Nutr. 2004;24:55-78.   DOI   ScienceOn
7 Zeng T, Xie KQ. Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis. Arch Toxicol. 2009;83(12):1075-81.   DOI
8 Kim YJ, Kim MC, Lee CH, Kim JU, Yook TH. The effect of needle-embedding therapy and pharmacopuncture therapy on patients with urinary incontinence. J Acupunct Meridian Stud. 2011;4(4):220-4.   DOI
9 Boh B. Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. Recent Pat Anticancer Drug Discov. 2013;8(3):255-87.   DOI
10 Kim JD, Kang DI. A descriptive statistical approach to the Korean pharmacopuncture therapy. J Acupunct Meridian Stud. 2010;3(3):141-9.   DOI   ScienceOn
11 Yin CS, Park HJ, Chae YB, Ha EY, Park HK, Lee HS, et al. Korean acupuncture: the individualized and practical acupuncture. Neurol Res. 2007;29 Suppl 1:S10-5.   DOI   ScienceOn
12 Xu Z, Chen X, Zhong Z, Chen L, Wang Y. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. Am J Chin Med. 2011;39(1):15-27.   DOI   ScienceOn
13 Weng CJ, Yen GC. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010;27(5):361-9.   DOI
14 Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247(10):3170-5.
15 Sanodiya BS, Thakur GS, Baghel RK, Prasad GB, Bisen PS. Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharm Biotechnol. 2009;10(8):717-42.   DOI   ScienceOn
16 Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev. 2007:13:265-301.   DOI
17 Chen P, Wang Z, Zeng L, Yang X, Wang S, Dong W, et al. A novel soluble beta-glucan salecan protects against acute alcoholinduced hepatotoxicity in mice. Bioscience, Biotechnology and Biochemistry. 2011;75:1990-93.   DOI   ScienceOn
18 Reuben A. Alcohol and the liver. Curr Opin Gastroenterol. 2006;22(3):263-71.
19 Bergheim I, McClain CJ, Arteel GE. Treatment of alcoholic liver disease. Dig Dis. 2005;23(3-4):275-84.   DOI   ScienceOn
20 Maddrey WC. Alcohol-induced liver disease. Clin Liver Dis. 2000;4(1):115-31.   DOI
21 Nordmann R. Alcohol and antioxidant systems. Alcohol and Alcoholism. 1994;29(5):513-22.
22 Osterreicher CH, Halangk J, Berg T, Patsenker E, Homann N, Hellerbrand C, et al. Evaluation of the transforming growth factor beta1 codon 25 (Arg $\rightarrow$ Pro) polymorphism in alcoholic liver disease. Cytokine. 2008;42(1):18-23.   DOI   ScienceOn
23 Meier P, Seitz HK. Age, alcohol metabolism and liver disease. Curr Opin Clin Nutr Metab Care. 2008;11(1):21-6.   DOI   ScienceOn
24 Tuma DJ, Casey CA. Dangerous byproducts of alcohol breakdown-focus on adducts. Alcohol Res Health. 2003;27(4):285-90.
25 Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol. 2009;83(6):519-48.   DOI   ScienceOn
26 Albano E, French SW, Ingelman-Sundberg M. Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci. 1999;4:533-40.   DOI
27 Wu D, Cederbaum AI. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health. 2003;27(4):277-84.
28 Leung TM, Nieto N. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol. 2013;58(2):395-8.   DOI   ScienceOn
29 Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis. 2009;29(2):141-54.   DOI   ScienceOn
30 Singh M, Gupta S, Singhal U, Pandey R, Aggarwal SK. Evaluation of the oxidative stress in chronic alcoholics. J Clin Diagn Res. 2013;7(8):1568-71.
31 Zeng T, Zhang CL, Song FY, Zhao XL, Yu LH, Zhu ZP, et al. The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress. Biochim Biophys Acta. 2013;1830(10):4848-59.   DOI   ScienceOn
32 Bianchi GP, Fiorella PL, Bargossi AM, Grossi G, Marchesini G. Reduced ubiquinone plasma levels in patients with liver cirrhosis and in chronic alcoholics. Liver. 1994;14(3):138-40.
33 Panda V, Ashar H, Srinath S. Antioxidant and hepatoprotective effect of garcinia indica fruit rind in ethanol-induced hepatic damage in rodents. Interdiscip Toxicol. 2012;5(4):207-13.
34 Singal AK, Chaha KS, Rasheed K, Anand BS. Liver transplantation in alcoholic liver disease current status and controversies. World J Gastroenterol. 2013;19(36):5953-63.   DOI   ScienceOn
35 Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141(5):1572-85.   DOI   ScienceOn
36 Wu X, Zeng J, Hu J, Liao Q, Zhou R, Zhang P, et al. Hepatoprotective effects of aqueous extract from lingzhi or reishi medicinal mushroom Ganoderma lucidum (higher basidiomycetes) on α-amanitin-induced liver injury in mice. Int J Med Mushrooms. 2013;15(4):383-91.   DOI
37 Orman ES, Odena G, Bataller R. Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol. 2013;28 Suppl 1:77-84.   DOI   ScienceOn
38 Crawford JM. Histologic findings in alcoholic liver disease. Clin Liver Dis. 2012;16(4):699-716.   DOI   ScienceOn
39 Helander A. Biological markers in alcoholism. J Neural Transm Suppl. 2003;(66):15-32.
40 Sharpe PC. Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem. 2001;38(6):652-64.   DOI   ScienceOn
41 Conigrave KM, Davies P, Haber P, Whitfield JB. Traditional markers of excessive alcohol use. Addiction. 2003;98 Suppl 2:31-43 .   DOI   ScienceOn
42 Amacher DE. Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol. 1998;27(2):119-30.   DOI   ScienceOn
43 Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology. 2006;43 Suppl 1:S63-74.   DOI   ScienceOn
44 Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int. 2011;31(10):1432-48.   DOI   ScienceOn
45 Dinda PK, Kossev P, Beck IT, Buell MG. Role of xanthine oxidase-derived oxidants and leukocytes in ethanol-induced jejunal mucosal injury. Dig Dis Sci. 1996;41(12):2461-70.   DOI
46 Thuluvath PJ, Triger DR. Selenium in chronic liver disease. J Hepatol. 1992;14(2-3):176-82.   DOI
47 Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farre S, et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med. 2004;25(1-2):191-8.   DOI   ScienceOn
48 Wu GS, Guo JJ, Bao JL, Li XW, Chen XP, Lu JJ, et al. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opin Investig Drugs. 2013;22(8):981-92.   DOI   ScienceOn